Volume dodolan perusahaan q32bio.com (QTTB)
Current revenue for Q32 Bio Inc. (QTTB) is based on strategic contracts, which creates capital pressure due to R&D expenditures. The company's sales timeline demonstrates an operating flow where the value 0.05 represents the current metric. Growth prospects rely on the commercialization of drugs for immune pathologies and the creation of unique fusion proteins for targeted restoration of the body's defenses.
Rincian analitis perusahaan Q32 Bio Inc (QTTB)
- rega lan prakiraan konsensus rega:
- rincian kapitalisasi pasar:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Q32 Bio Inc.|QTTB - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Q32 Bio Corp|QTTB - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Q32 Bio Inc.|QTTB - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Q32 Bio|Likuiditas darurat q32bio.com
- data bathi bisnis lan rasio investasi:
QTTB - Penghasilan resik|Penghasilan resik sing dikarepake Q32 Bio Inc.|QTTB - Pangali P/E|Kapitalisasi marang proyeksi bathi Q32 Bio Corp|QTTB - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Q32 Bio Inc.|QTTB - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Q32 Bio|QTTB - Bathi resik saben saham sajrone 12 wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan q32bio.com|QTTB - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Q32 Bio Inc.
- indikator volume dodolan lan pendapatan:
Ringkesan analisis perusahaan:q32bio.com
Q32 Bio Inc. (QTTB) brings together the elite of immunobiology to create innovative drugs. This indicator captures the actual daily cash inflow, excluding market noise and emotional price fluctuations. By analyzing the company's commercial revenue, an investor can objectively assess the pace of business expansion and the risk of asset overvaluation. The steady expansion of this flow confirms the effectiveness of the scientific strategy and the fundamental stability of the company.
Pesaing wigati
Pendapatan lan volume dodolan argenx BVBA|Pendapatan perusahaan BioNTech SE (BNTX)|Abivax SA - Volume dodolan perusahaan|Pendapatan lan volume dodolan ADMA (ADMA Biologics, Inc.)|Protagonist Therapeutics, Inc. (PTGX) - Total pendapatan perusahaan|IMVT - Pendapatan perusahaan|Total volume dodolan perusahaan Kiniksa Corp (KNSA)|GRFS (Grifols, S.A.) - Dodolan perusahaan|ADPT (adaptivebiotech.com) - Pendapatan perusahaan|Dodolan perusahaan CLDX|AUPH: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan BCRX|Pendapatan perusahaan VERA (Vera Corp)|Pendapatan lan volume dodolan DNTH (Dianthus Therapeutics)|Pendapatan reged perusahaan pharvaris.com (PHVS)|ABCL - Pendapatan perusahaan|Total pendapatan perusahaan Tourmaline Bio Inc|PGEN (Intrexon) - Dodolan perusahaan|Pharming Corp - Pendapatan dodolan perusahaan|NKTR (Nektar Therapeutics) - Pendapatan lan volume dodolan|upstreambio.com (UPB) - Pendapatan reged perusahaan|Pendapatan perusahaan Zenas Biopharma (ZBIO)|Immunome Inc - Volume dodolan perusahaan|Pendapatan lan volume dodolan GOSS (Gossamer Corp)|KALV - Dodolan perusahaan|SEPN: Dodolan perusahaan|Pendapatan reged perusahaan pieris.com PVLA|Savara (SVRA) - Pendapatan perusahaan|Total volume dodolan perusahaan Rigel Pharma RIGL|Dodolan perusahaan ANAB|ATXS (Astria Corp) - Total dodolan perusahaan|Dodolan perusahaan ENGN (enGene Holdings Inc.)|Total dodolan perusahaan RAPT|Pendapatan lan volume dodolan JBIO (Aerovate Therapeutics)|Aclaris Therapeutics Inc. - Pendapatan perusahaan|KYTX - Pendapatan perusahaan|Pendapatan tahunan perusahaan TLSA|CABA: Pendapatan lan volume dodolan|ventyxbio.com - Pendapatan dodolan perusahaan|THTX (Theratechnologies) - Pendapatan lan volume dodolan|Pendapatan lan volume dodolan Avalo Therapeutics, Inc.|Pendapatan perusahaan Eledon (ELDN)|AGEN (Agenus, Inc) - Pendapatan dodolan perusahaan|Pendapatan perusahaan Climb Bio Inc CLYM|ZURA - Dodolan perusahaan|aTyr Pharma - Pendapatan lan volume dodolan|ADAG - Pendapatan lan volume dodolan|IMA (ikenaoncology.com) - Dodolan perusahaan|Shattuck Labs - Pendapatan dodolan perusahaan|EQ (Equillium Inc) - Pendapatan lan volume dodolan|Connect Pharma (CNTB) - Pendapatan reged perusahaan|Pendapatan perusahaan Immunic, Inc. (IMUX)|Dodolan perusahaan atarabio.com ATRA|Pendapatan perusahaan InflaRx IFRX|XFOR - Dodolan perusahaan|ACET: Dodolan perusahaan|CELU - Pendapatan lan volume dodolan|INmune Bio (INMB) - Pendapatan perusahaan|Volume dodolan perusahaan BRNS|KZR (Kezar Life Sciences, Inc) - Pendapatan lan volume dodolan|Total pendapatan perusahaan SAB Biotherapeutics Inc SABS|Pendapatan perusahaan Akari Therapeutics (AKTX)|enlivex.com (ENLV) - Total volume dodolan perusahaan|GeoVax - Dodolan perusahaan|Edesa Biotech Inc - Pendapatan perusahaan|IBIO: Dodolan perusahaan|Pendapatan dodolan perusahaan CARM (Carisma Therapeutics)|XTLB: Pendapatan lan volume dodolan|BOLT (Bolt Biotherapeutics, Inc.) - Pendapatan perusahaan|HCWB (HCW Biologics, Inc.) - Pendapatan lan volume dodolan|Aptevo (APVO) - Pendapatan reged perusahaan|Pendapatan perusahaan AIM ImmunoTech (AIM)|ADTX - Total pendapatan perusahaan|GRI Bio, Inc. - Dodolan perusahaan|Pendapatan dodolan perusahaan XRTX|Vyome Holdings - Pendapatan lan volume dodolan|Pendapatan reged perusahaan Revelation Biosciences Inc REVB|Indaptus (INDP) - Pendapatan perusahaan|Volume dodolan perusahaan SCNI|CALI (CalciMedica Inc) - Pendapatan lan volume dodolan|Dodolan perusahaan Affimed Therapeutics (AFMD)|Dodolan perusahaan ALLK (Allakos Inc.)|Pendapatan reged perusahaan hookipapharma.com|Pendapatan perusahaan IGM Biosciences IGMS|Total volume dodolan perusahaan iTeos Pharma|OCEA: Dodolan perusahaan|tcbiopharm.com - Total dodolan perusahaan|THRD (Third Harmonic Bio, Inc.) - Dodolan perusahaan
